Obsidian Therapeutics files S-1 for resale of 29.16 million shares post-merger with GaleraAug 28FinancingObsidian Therapeutics, Inc.
Obsidian Therapeutics completes merger with Galera, closes $350 million private placementAug 3FinancingObsidian Therapeutics, Inc.
Sign inSign in